Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » 23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows By Reuters
    News

    23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows By Reuters

    userBy userSeptember 30, 2024No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    (Reuters) – Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on Monday.

    “It has become even clearer to me that the best path forward for the (company) is for me to take the company private,” Wojcicki said.

    Wojcicki had said earlier this month she would consider third-party takeover proposals while continuing to evaluate and negotiate a deal.

    In July, the CEO and co-founder proposed to acquire all outstanding shares of the firm not already owned by her or her affiliates for $0.40 each.

    The independent directors of the company resigned earlier this month saying they had not received a satisfactory take-private offer in the best interests of the non-affiliated shareholders.

    23andMe, which provides DNA testing that helps users learn more about their ancestry, went public in 2021.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleStock market today: Live updates
    Next Article RTX’s Pratt & Whitney awarded F135 Engine Core Upgrade contract By Investing.com
    user
    • Website

    Related Posts

    Govt, private banks and SFBs compared

    June 7, 2025

    Has Warren Buffett made his best move ever selling his Apple stock?

    June 7, 2025

    This FTSE 100 stock goes ex-dividend on 26 June — time to bag a 6.9% yield?

    June 7, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d